v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT04944147 |
|
Full text link
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
agnes.floeel@med.uni-greifswald.de |
|
Registration date
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
2021-06-29 |
|
Recruitment status
Last imported at : May 13, 2022, 7 a.m. Source : ClinicalTrials.gov |
Recruiting |
|
Study design
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Long covid |
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: history of covid-19 condition at least 4-6 weeks prior to study inclusion self-reported concerns regarding cognitive functioning. age: 18-60 years. |
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
acute covid-19 illness. history of dementia before covid-19. other neurodegenerative neurological disorders; epilepsy or history of seizures. severe and untreated medical conditions that preclude participation in the training, as determined by responsible physician. history of severe alcoholism or use of drugs. severe psychiatric disorders such as severe depression (if not in remission) or psychosis. contraindication to tdcs application (antal et al. 2017). |
|
Number of arms
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
3 |
|
Funding
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
University Medicine Greifswald |
|
Inclusion age min
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
60 |
|
Countries
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Germany |
|
Type of patients
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
|
Severity scale
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
60 |
|
primary outcome
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
Working memory performance at post-assessment |
|
Notes
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : July 1, 2021, 2:30 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1527, "treatment_name": "High-definition transcranial direct current stimulation (hd-tdcs)+intensive cognitive training", "treatment_type": "Medical device+rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 661, "treatment_name": "Intensive cognitive training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "Progressive muscle relaxation", "treatment_id": 837, "treatment_name": "Muscle relaxation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |